MDM2 emerges as key; Software could expose metabolomic information of other diseases —
A new bioinformatic framework developed by researchers at University of California San Diego School of Medicine has identified key proteins significantly altered at the gene-expression level in biopsied tissue from patients with diabetic kidney disease, a result that may reveal new therapeutic targets. … Read the Full Story from the UC San Diego Newsroom

He directs the Institute for Metabolomic Medicine and the Center for Renal Translational Medicine at UC San Diego School of Medicine.